Summary
PeptiDream Inc. (PeptiDream) is a biopharmaceutical company, which discovers and develops peptide therapeutics to address unmet medical needs. PeptiDream harnesses its proprietary Peptide Discovery Platform System (PDPS), a peptide generation and selection platform, which comprises three core technologies; Flexizyme; Translation, cyclization, and peptide modifying technologies; and PD display. The combination of these technologies enables the production of peptide libraries for the development of peptide-based products. The company offers products for the treatment of Alzheimer's disease and amyotrophic lateral sclerosis (ALS), among others. It collaborates with Novartis, Amgen, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma, Ipsen, Daiichi-Sankyo, Lilly, GlaxoSmithKline and AstraZeneca. The company operates a state-of-the-art commercial research center at the University of Tokyo's Komaba Research Campus. PeptiDream is headquartered in Meguro ku, Tokyo, Japan.
PeptiDream Inc. (4587) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
PeptiDream Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
PeptiDream Inc., Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12
Private Equity 13
Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 13
Partnerships 14
PeptiDream Enters into Research Agreement with BIND Therapeutics 14
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 15
PeptiDream Enters into Agreement with Shionogi 16
PeptiDream Enters into Agreement with Genentech 17
Teijin Pharma Enters into Discovery Agreement with PeptiDream 18
PeptiDream Enters into Discovery Agreement with Sanofi 19
PeptiDream Enters into Peptide Discovery Agreement with Merck 20
PeptiDream Expands Drug Discovery Agreement with Novartis 21
PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 22
PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 23
PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 25
PeptiDream Expands Drug Discovery Agreement with Amgen 26
PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 27
PeptiDream Enters into Drug Discovery Agreement with MedImmune 28
PeptiDream Extends Discovery Agreement With Bristol-Myers Squibb 29
PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 30
PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 31
PeptiDream Enters into Discovery Agreement with Pfizer 32
PeptiDream Enters into Drug Discovery Agreement with Mitsubishi Tanabe Pharma 33
PeptiDream Enters into Drug Discovery Agreement with Amgen 34
PeptiDream Enters into Discovery Agreement with Bristol-Myers Squibb 35
PeptiDream Enters into Macrocylic Peptide Drug Discovery Agreement with Novartis 36
Licensing Agreements 37
Eli Lilly Enters into Licensing Agreement with PeptiDream 37
PeptiDream Exercises Option for Licensing Agreement with Novartis 38
PeptiDream Enters Into Licensing Agreement With Eli Lilly 39
PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40
PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41
Equity Offering 42
PeptiDream Raises USD53 Million in IPO 42
PeptiDream Inc. - Key Competitors 43
Key Employees 44
Locations And Subsidiaries 45
Head Office 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
PeptiDream Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
PeptiDream Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
PeptiDream Inc., Deals By Therapy Area, 2010 to YTD 2016 9
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12
Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 13
PeptiDream Enters into Research Agreement with BIND Therapeutics 14
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 15
PeptiDream Enters into Agreement with Shionogi 16
PeptiDream Enters into Agreement with Genentech 17
Teijin Pharma Enters into Discovery Agreement with PeptiDream 18
PeptiDream Enters into Discovery Agreement with Sanofi 19
PeptiDream Enters into Peptide Discovery Agreement with Merck 20
PeptiDream Expands Drug Discovery Agreement with Novartis 21
PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 22
PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 23
PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 25
PeptiDream Expands Drug Discovery Agreement with Amgen 26
PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 27
PeptiDream Enters into Drug Discovery Agreement with MedImmune 28
PeptiDream Extends Discovery Agreement With Bristol-Myers Squibb 29
PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 30
PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 31
PeptiDream Enters into Discovery Agreement with Pfizer 32
PeptiDream Enters into Drug Discovery Agreement with Mitsubishi Tanabe Pharma 33
PeptiDream Enters into Drug Discovery Agreement with Amgen 34
PeptiDream Enters into Discovery Agreement with Bristol-Myers Squibb 35
PeptiDream Enters into Macrocylic Peptide Drug Discovery Agreement with Novartis 36
Eli Lilly Enters into Licensing Agreement with PeptiDream 37
PeptiDream Exercises Option for Licensing Agreement with Novartis 38
PeptiDream Enters Into Licensing Agreement With Eli Lilly 39
PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40
PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41
PeptiDream Raises USD53 Million in IPO 42
PeptiDream Inc., Key Competitors 43
PeptiDream Inc., Key Employees 44
List of Figures
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
PeptiDream Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
